6.000
−20,00%
2026-10-16
Fundamental Analysis
67 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +728.4% | +233.0% | 2 / 3 | +3.8% | +2.87 pp | +0.66 pp | +1.9% | 0.56 | 29.00 | 165 | +3,8% | 1,2 | +728,4% | 29.00 | 57.79 | −49,8% |
| Pts | 12 | 12 | 8 | 0 | 8 | 8 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 6.000 (close price on 2026-10-16)EPS (TTM): 206,9
Financial charts
1.Revenue & growth
VND bn165Q2/26
1.Revenue & growth
VND bn165Q2/26
2.Profit & growth
VND bn1,25Q2/26
3.Profit mix (Penman)
VND bn4,15Q2/26
4.Margins & cost structure
%6.1%Q2/26
5.Returns & cash cycle
% · days3.6%Q2/26
6.Earnings quality & cash
VND bn-39,6Q2/26
7.Asset structure
VND bn382Q2/26
8.Funding & debt health
VND bn · times382Q2/26
9.Revenue backlog
VND bn56,9Q2/26
10.Valuation
times · %29,0×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %80Q2/26
Adjusted EPS growth, latest quarter
728%
Average adjusted EPS growth, 3 quarters
233%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26